The Challenge
- Historically, MSL Focus Lists have been geared towards Scientific Key Opinion Leaders (KOLs), who are practice or TA experts that educate their peers through papers, congresses/lectures, and act as editors of publications. This approach alone may miss the opportunity to integrate real-world insights from community HCPs.
- To bridge the gap between science and practice, an enhanced strategy is needed to maintain relationships with Scientific KOLs while identifying Community KOLs who influence local adoption of therapies.
Our Solution
Propensity4 developed a dual arch-typing approach
- Clinical Archetyping: Focus on Scientific KOLs for high-level scientific dialogue.
- Community Archetyping: Identify Community KOLs influencing local prescribing behaviors.
- Integrated Targeting: Prioritize individuals who “practice what they teach,” combining scientific expertise and practical influence.
The Results
- Enhanced engagement by bridging science and practice.
- Improved alignment of MSL resources with high-value targets.
- Streamlined geographic coverage for impactful interactions.
Combining Clinical and Community KOLs transforms MSL targeting, enabling impactful engagement that advances therapeutic adoption and patient outcomes.
Case Example: Dermatology Analysis
- Analysis of 735 client identified Clinical KOLs with all HCP biologic prescribers revealed 50% of Clinical KOLs aligned within the top 6 Community KOL archetypes.
- In our final analysis, all Clinical KOLs were promoted to “Priority” to maintain critical Clinical KOL relationships and simplify the broader MSL engagement strategy.
Learn more about our work.
Jump to a slide with the slide dots.
Powering a U.S. Launch: Building a Commercial Infrastructure from the Ground Up
End-to-end US launch support for EU client’s dry eye device—from KAM team and CRM setup to data analytics, targeting, and incentive strategy.
Read more
Chris Savage
Improve your forecast with “bottom-up” methodologies
This blog explores how “bottom-up” forecasting, particularly Most Probable Forecasting (MPF), enhances pharmaceutical brand planning.
Read more
Predictive Patient Engagement Program
Personalized patient engagement boosted therapy adherence with AI-driven insights, risk scoring, and tailored support recommendations.
Read more
Isabelle Amick
Rare-disease patient finding: Identifying the “right” patients at the “right” time.
Accelerating rare disease diagnosis through data-driven patient finding and predictive modeling to connect patients with the right HCPs faster.
Read more
Dynamic Targeting Enhances Field Effectiveness without Expanding Teams
Propensity4 reduced field target lists by 97% with a dynamic targeting framework that improved prioritization and protected KPI performance.
Read more